Esketamine (Spravato) for Treatment-Resistant Depression: Clinic Sessions, Side Effects and the Tablet Taken With It
🧠 Some people with major depression try one antidepressant, then a second, sometimes a third, and still wake up each morning with the same heavy fog. Esketamine, sold as the nasal spray Spravato, was developed for exactly this group: adults whose depression has not lifted after at least two proper courses of treatment. 💡 It works through a different brain system than the usual tablets, it can act within days rather than weeks, and it is given only in a certified clinic, where the patient stays under observation for at least two hours after each dose. This guide explains what esketamine is, who it suits and who should avoid it, what a session looks like from arrival to the trip home, which side effects to expect, why an oral antidepressant usually runs alongside it, and what other options exist when the spray is not available or not suitable.
🧪 What esketamine is and how it differs from ketamine
🔬 Ketamine is an old anaesthetic that has been used in operating theatres and emergency rooms for decades. Like many medicines, it is a mix of two mirror-image molecules. Esketamine is one of those two halves, the S form, which binds more strongly to its target in the brain. Because it is more potent, smaller amounts are needed. In some countries esketamine has long been used by injection for anaesthesia and pain relief; the nasal spray for depression is a separate product with its own dose, rules and safety program. 📖 Racemic ketamine given by drip for depression is used off-label in some clinics, while the esketamine nasal spray is the version that went through full regulatory trials for depression.
📆 How the spray reached patients
🗓️ Older summaries of esketamine sometimes give the wrong dates or describe it as a home medicine. The nasal spray was first approved for depression in 2019, and its use has widened step by step as more trial data arrived. The timeline below shows the main milestones in the United States and Europe.
US approval for treatment-resistant depression, with an oral antidepressant
European approval for treatment-resistant depression
Added use: depression with acute suicidal thoughts or behaviour
US label allows use on its own for treatment-resistant depression
🔍 What counts as treatment-resistant depression
📋 Doctors do not call depression “treatment-resistant” just because the first tablet felt weak. The usual definition is no adequate response to at least two different antidepressants, each taken at a proper dose for long enough, during the current episode. Before using the label, a careful psychiatrist checks that the earlier treatments really had a fair chance. 📖 If you are still at the first or second medicine, the article when the first antidepressant does not work explains the steps that usually come before esketamine.
⚡ How esketamine works in the brain
🧬 Most antidepressants act on serotonin, noradrenaline or dopamine, and their effect builds slowly over weeks. Esketamine works on glutamate, the main excitatory signal of the brain, by blocking a receptor called NMDA. This sets off a short chain of events that seems to help nerve cells in mood circuits rebuild connections that chronic stress and depression have worn down.
⏱️ This explains two features patients notice. Some feel a lift in mood within hours to days, much faster than with tablets, and the effect fades if sessions stop too early, because the new connections need repeated support. The same NMDA blocking is also what causes the strange, dreamy feeling during the first hour after a dose.
🧭 Who may be offered esketamine
Not bipolar, not a medical mimic
Full dose, enough weeks
Blood pressure, vessels, substance use
Transport home, time off for 2 hours plus
With a review after about 4 weeks
🚨 There is a second group: adults with major depression and acute suicidal thoughts or behaviour, where a faster-acting option is wanted alongside standard emergency care. In this setting esketamine never replaces hospital assessment or crisis support; it is one tool used by a psychiatric team, often while the person is closely followed.
⛔ Who should not use esketamine
🩺 Because esketamine raises blood pressure for a short time and affects perception, a small number of conditions rule it out completely, and others need extra caution. A clinic will check blood pressure, heart history and past substance use before the first dose.
| 🚫 Situation | 📝 Why it matters |
|---|---|
| Aneurysm of the aorta, brain or other arteries | A blood pressure rise could make it rupture; this is a contraindication |
| Arteriovenous malformation | Fragile abnormal vessels; contraindication |
| Past bleeding inside the brain | Risk of a new bleed with blood pressure spikes; contraindication |
| Uncontrolled high blood pressure | Must be treated and stable first |
| Recent heart attack, stroke or unstable heart disease | Specialist review needed; often not suitable |
| Psychosis now or in the past | Dissociation may worsen symptoms |
| History of drug or alcohol misuse | Esketamine has abuse potential; careful risk review |
| Pregnancy or breastfeeding | Not recommended; animal data raise concern for the developing brain |
💊 Why a tablet usually runs alongside the spray
🤝 In the main trials, esketamine was always started together with a new oral antidepressant. The spray brings a fast early effect, while the tablet builds a slower, steady base that helps keep the improvement going. Even after the 2025 US label change that allows esketamine on its own, most psychiatrists still pair it with an oral antidepressant, especially in Europe, where the licence is for combined use. The tablet is usually a newly started medicine the patient has not failed before.
⚖️ Choosing the tablet partner
🤔 There is no single best partner drug. The choice depends on what was tried before, which side effects the person can live with, and what other symptoms need help. If the patient has already failed two SSRIs, switching to an SNRI often makes sense; if pain or fatigue dominate, duloxetine may be preferred; if blood pressure is borderline, a drug with less effect on it is chosen, since esketamine itself raises blood pressure for a few hours.
| 🧩 Situation | ✅ Often considered | ⚠️ Watch for |
|---|---|---|
| Two SSRIs failed already | Duloxetine or venlafaxine XR | Nausea early on, sweating, discontinuation symptoms |
| Chronic pain with depression | Duloxetine | Liver disease, heavy drinking |
| Borderline high blood pressure | Escitalopram or sertraline | Venlafaxine can raise blood pressure at higher doses |
| Many other medicines | Escitalopram or sertraline | QT effects of citalopram and escitalopram at high doses |
| Poor tolerance of SNRIs in the past | An SSRI not tried before | Sexual side effects, early jitteriness |
📖 What to expect from any of these tablets in the first weeks, from nausea to sleep changes, is covered in antidepressant side effects and the first weeks.
📝 Preparing for a session
🍽️ Small practical steps make sessions easier and reduce nausea. Most clinics give a printed list; the points below are the usual core of it.
🏥 What happens in the clinic room
🛋️ A session follows the same pattern each time. The patient sprays the medicine personally, but a nurse or doctor watches every step and stays nearby until it is safe to leave. Each device holds 28 mg, given as one spray in each nostril; two devices give 56 mg and three give 84 mg, with a 5-minute pause between devices.
📅 The dosing schedule by phase
📈 Esketamine is not a single dose. Treatment runs in phases: an intensive start, a weekly bridge, and then a maintenance rhythm that is adjusted to keep the response going with as few visits as possible.
😵💫 Side effects during the first two hours
🌀 Most side effects appear soon after the dose and settle on the same day. They are the main reason for the two-hour observation rule, and they often become milder after the first few sessions as the person knows what to expect.
💬 Anxiety, a feeling of being drunk, headache and blurred vision are also reported. Rarely, sedation can deepen into reduced breathing, especially when other sedating medicines are involved, which is why staff watch alertness and breathing until discharge.
💓 Blood pressure checks
📊 In most people the rise is modest and returns to the starting level within a few hours. The concern is for people with fragile blood vessels or heart disease, which is why those conditions are screened before the first session.
🌌 Dissociation: what it feels like and how to cope
👁️ Dissociation is the side effect people worry about most. It usually starts within minutes, peaks around 40 minutes and has largely passed by the end of the observation period. People describe colours or sounds feeling strange, the body feeling light or heavy, time stretching, or watching themselves from a distance. For some it is mildly pleasant, for others unsettling. It is not the same as a psychotic episode, and it does not mean the treatment is damaging the brain.
🚗 Driving, work and the rest of the day
🚫 Reaction time and judgement can stay off for hours after the clinic visit, even when the person feels normal. The rule is simple: no driving, cycling or operating machinery until the next day, after a restful sleep. Many people plan sessions for the afternoon or late morning and keep the rest of the day free.
🔬 Longer-term safety questions
📋 Because esketamine is related to a drug that is misused recreationally, regulators added strict controls. The main long-term questions are misuse, bladder problems and effects on memory, and so far clinic-based use at approved doses has looked very different from street ketamine use.
🔒 Misuse: the spray is never handed out for home use. Every device is used under supervision, and clinics watch for signs of craving or requests for more frequent doses.
🚻 Bladder: heavy recreational ketamine use can damage the bladder. Report pain on passing urine, needing to go very often, or blood in the urine.
🧠 Memory and thinking: long-term data in clinic patients have been reassuring so far, but the team reviews concentration and memory over time, especially in older adults.
📊 Suicidal thoughts: like all antidepressants, esketamine carries a warning about suicidal thoughts in young people, so mood is checked at each visit.
🔗 Interactions to know about
| 💊 Medicine or substance | ⚠️ Possible effect | 📝 Usual approach |
|---|---|---|
| Benzodiazepines, sleeping pills | More sedation; may weaken the antidepressant effect | Lowest dose, timing reviewed |
| Opioid painkillers | Added sedation and slower breathing | Closer observation |
| Alcohol | Sedation, falls, worse mood | Avoid on treatment days, ideally cut down overall |
| Stimulants (ADHD medicines, modafinil) | Higher blood pressure | Blood pressure monitored closely |
| MAO inhibitors | Higher blood pressure | Close monitoring or avoid |
| Nasal decongestant or steroid spray | May change absorption | Use at least 1 hour before dosing |
⏳ How fast it works and how response is judged
📈 One of the reasons esketamine attracted attention is speed. Some people notice changes within the first week, often first in energy, sleep or a lifting of the constant dark thinking, before mood itself improves. Others need the full induction phase. The psychiatrist usually uses a short rating scale at the start and again at about 4 weeks to judge the change honestly rather than relying on how one session felt.
🔁 In a long-term trial, people who had responded and then kept up maintenance sessions were less likely to relapse than those switched to a dummy spray. Stopping too soon is one of the most common reasons the benefit fades, so changes in session frequency are made gradually and with the psychiatrist.
🧩 If esketamine is not suitable or not available
🌍 Esketamine is expensive, needs a certified clinic and suits only some patients. Several add-on tablets have good evidence in resistant depression and can be started by a psychiatrist in an ordinary clinic. In a large head-to-head trial, esketamine with an SSRI or SNRI led to more remissions at 8 weeks than adding quetiapine, but the tablet options remain important and widely used.
📖 Who suits quetiapine as an add-on, and which checks it needs, is covered in quetiapine as an add-on for major depression.
⚖️ Esketamine compared with other options for hard-to-treat depression
| 🧩 Option | ⏱️ Speed | 🏥 Setting | ⚠️ Main drawbacks |
|---|---|---|---|
| Esketamine nasal spray | Days to weeks | Certified clinic, 2 hours per visit | Dissociation, blood pressure rise, no driving that day, cost |
| Ketamine by drip (off-label) | Hours to days | Specialist clinic | Similar effects; protocols vary; less long-term data |
| Add-on tablet (aripiprazole, quetiapine, lithium) | 2 to 6 weeks | Home, with regular reviews | Weight, restlessness, blood tests for lithium |
| Repetitive TMS | 3 to 6 weeks | Daily outpatient sessions | Many visits, scalp discomfort, rare seizures |
| Electroconvulsive therapy | 1 to 3 weeks | Hospital, general anaesthesia | Short-term memory problems, anaesthesia each time |
💬 These options are not mutually exclusive. Talking therapy, especially CBT or behavioural activation, adds to every one of them and is particularly useful once the fog lifts enough for the person to engage.
🆘 Esketamine and suicidal thoughts
🚨 Severe depression with suicidal thinking is a medical emergency. Esketamine is approved as part of treatment for adults with depression and acute suicidal thoughts or behaviour, but always within a full crisis plan: assessment, safety planning, removal of means, close follow-up and often a hospital stay. In trials it eased depressive symptoms faster than standard care alone within the first day, but it was not proven to prevent suicide on its own. Nobody should wait for a clinic appointment if they feel unsafe.
📞 If you have thoughts of ending your life, contact local emergency services or a crisis line now, or go to the nearest emergency department. Tell someone you trust how you feel today.
👥 Older adults, pregnancy and liver problems
🤰 For women who become pregnant during treatment, the psychiatrist and obstetric team discuss safer ways to keep depression controlled. Stopping all treatment suddenly is not a safe default, since untreated severe depression also carries risks for mother and baby.
🗿 Myths and facts about esketamine
🏠 Living between sessions
🌱 The days between visits matter as much as the clinic hours. Esketamine seems to open a window in which the brain is more able to change, and many psychiatrists encourage people to use that window for small, concrete steps.
🚨 When to see a doctor
⛔ Contact your psychiatrist or seek care promptly if:
🔹 You have thoughts of suicide or self-harm, or they get stronger. In that case, call emergency services or a crisis line now.
🔹 You get a severe headache, chest pain, sudden weakness or confusion after a session.
🔹 Dissociation, panic or strange perceptions last into the next day.
🔹 You feel unusually high, wired, need little sleep or spend recklessly, which may signal a switch into mania.
🔹 You notice pain on passing urine, blood in the urine or needing to go much more often.
🔹 You feel a strong urge for more frequent doses or cravings between sessions.
❓ Frequently asked questions
What is esketamine used for?
As a nasal spray, it treats adults with depression that has not improved after at least two antidepressants, and depression with acute suicidal thoughts as part of a full crisis plan.
Can I use the esketamine spray at home?
No. Every dose is taken in a certified clinic under supervision, followed by at least two hours of observation.
How quickly does esketamine work?
Some people notice changes within days. The benefit is usually judged at the end of the first 4 weeks of twice-weekly sessions.
What are the most common side effects?
Dissociation, dizziness, nausea, sleepiness, a short rise in blood pressure and an odd taste. They usually fade within the observation period.
Can I drive after an esketamine session?
No. Do not drive or operate machinery until the next day after a restful night of sleep, so arrange a lift home.
Do I still need an antidepressant tablet with esketamine?
Usually yes. In most plans a newly started SSRI or SNRI, such as duloxetine, venlafaxine, escitalopram or sertraline, runs alongside the spray.
Who should not take esketamine?
People with an aneurysm, arteriovenous malformation or past brain bleed, and it is generally avoided in pregnancy, uncontrolled high blood pressure and active psychosis.
Is esketamine addictive?
It has abuse potential, which is why it is only given in clinics. At supervised doses misuse is uncommon, but clinics watch for craving.
How is esketamine different from ketamine infusions?
Esketamine is one half of the ketamine molecule, given as an approved nasal spray. Ketamine drips are used off-label with varying protocols.
What are the options if esketamine is not suitable?
Add-on aripiprazole, quetiapine or lithium, combining antidepressants, talking therapy, TMS or ECT, chosen with a psychiatrist.
📑 Sources and editorial
- 📘 Official prescribing information and safety program documents for esketamine nasal spray
- 🧪 Randomised trials of esketamine with a new oral antidepressant in treatment-resistant depression
- 🔁 Long-term relapse prevention and safety extension studies of esketamine
- ⚖️ Head-to-head trial of esketamine versus quetiapine augmentation
- 🧠 Clinical guidelines on the management of treatment-resistant depression
- 💊 Reviews of augmentation strategies with antipsychotics, lithium and antidepressant combinations
- 📖 Related reading: when the first antidepressant does not work, quetiapine as an add-on, bipolar 2 or depression, antidepressant side effects, major depressive disorder
- 🛒 Related products: Cymbalta (Duloxetine), Effexor (Venlafaxine), Lexapro (Escitalopram), Sertafine (Sertraline), Abilify (Aripiprazole), Seroquel (Quetiapine), Lithobid (Lithium), Wellbutrin (Bupropion), Remeron (Mirtazapine)
- 🩺 RXshop Editorial Team — reviewed by Thomas Walsh, MD — Psychiatrist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.